Module 2: Treatment options for cardio-renal-metabolic disease

Learning Objectives:

• Understand the risk between CRM conditions and their long-term complications.
• Explore national and European guidance for the pharmacological management of key CRM conditions and how they link with each other.
• Systematically work through the management of a case with CRM disease
• Reflect on overall goals of treatment and individual priorities for patients with CRM conditions.

Module 3: Case based learning in cardio-renal-metabolic disease

Tuesday 26th November 2024 1-2pm

To register for this free educational session please email karis.ramsay1@nhs.net